Swarnim Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 19-05-2024
- Paid Up Capital ₹ 0.50 M
as on 19-05-2024
- Company Age 2 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
About Swarnim Pharmaceuticals
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Narendra Singh, Alka Kumari, and Sanjay Kumar serve as directors at the Company.
- CIN/LLPIN
U24230BR2022PTC059157
- Company No.
059157
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jul 2022
- Date of AGM
25 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Patna, Bihar, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Swarnim Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narendra Singh  | Additional Director | 15-Jan-2024 | Current |
| Alka Kumari | Director | 25-Jul-2022 | Current |
| Sanjay Kumar | Director | 25-Jul-2022 | Current |
Financial Performance of Swarnim Pharmaceuticals.
Enhance accessibility to Swarnim Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Swarnim Pharmaceuticals?
Unlock access to Swarnim Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Tradecart Infra Private LimitedActive 1 year 3 monthsNarendra Singh and Sanjay Kumar are mutual person
- Shaivyadev Enterprises Private LimitedActive 11 months 9 days
Narendra Singh and Sanjay Kumar are mutual person
- Bimamart Imf Private LimitedActive 10 months 10 days
Narendra Singh and Sanjay Kumar are mutual person
- Saan International Private LimitedActive 9 months 25 days
Alka Kumari and Sanjay Kumar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Swarnim Pharmaceuticals?
Swarnim Pharmaceuticals has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Swarnim Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Swarnim Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
